SK Bioscience Co Ltd (302440) — Cash Flow Reinvestment Rate
SK Bioscience Co Ltd (302440) has a Cash Flow Reinvestment Rate of 4.95x as of September 2025, reinvesting ₩102.27 Billion (capex ₩70.94 Billion plus investments ₩-31.32 Billion) from operating cash flow of ₩20.65 Billion. Check how high is SK Bioscience Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
SK Bioscience Co Ltd Cash Flow Reinvestment Rate (2018–2023)
Historical reinvestment intensity for SK Bioscience Co Ltd across 5 annual periods. Explore SK Bioscience Co Ltd (302440) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for SK Bioscience Co Ltd (2018–2023)
Year-by-year capital reinvestment analysis for SK Bioscience Co Ltd. For live market cap and broader valuation context, see SK Bioscience Co Ltd (302440) total market value.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 3.26x | ₩95.57 Billion | ₩29.35 Billion | ₩50.30 Billion | ▲ +22.4% |
| 2021 | 2.66x | ₩1.43 Trillion | ₩536.59 Billion | ₩42.91 Billion | ▲ +184.7% |
| 2020 | 0.93x | ₩112.32 Billion | ₩120.22 Billion | ₩9.93 Billion | ▼ -45.0% |
| 2019 | 1.70x | ₩37.06 Billion | ₩21.82 Billion | ₩23.97 Billion | ▲ +5.7% |
| 2018 | 1.61x | ₩23.95 Billion | ₩14.90 Billion | ₩6.31 Billion | — |